Xtrackers MSCI Europe Screened UCITS ETF (LON:XEUM)
London · Delayed Price · Currency is GBP · Price in GBX | Assets | 61.83M |
| Expense Ratio | 0.12% |
| PE Ratio | 15.98 |
| Dividend (ttm) | n/a |
| Dividend Yield | n/a |
| Ex-Dividend Date | n/a |
| Payout Frequency | n/a |
| Payout Ratio | n/a |
| 1-Year Return | +10.01% |
| Volume | n/a |
| Open | n/a |
| Previous Close | 15,084 |
| Day's Range | n/a |
| 52-Week Low | 12,596 |
| 52-Week High | 15,475 |
| Beta | 0.77 |
| Holdings | 391 |
| Inception Date | Jan 17, 2008 |
About XEUM
Xtrackers MSCI Europe Screened UCITS ETF is an exchange traded fund launched by Deutsche Asset & Wealth Management Investment S.A. The fund is managed by State Street Global Advisors Limited. It invests in the public equity markets of developed countries in Europe. The fund seeks to invest in the stocks of companies operating across diversified sectors. It invests in the stocks of mid-cap companies. The fund seeks to replicate the performance of the MSCI Total Return Net Europe Mid Cap Index, by investing in the stocks of companies as per their weightings in the index. Xtrackers MSCI Europe Screened UCITS ETF was formed on January 17, 2008 and is domiciled in Luxembourg.
Performance
XEUM had a total return of 10.01% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.87%.
Top 10 Holdings
20.14% of assets| Name | Symbol | Weight |
|---|---|---|
| SAP SE | SAP | 2.65% |
| ASML Holding N.V. | ASML | 2.45% |
| Siemens Aktiengesellschaft | SIE | 2.12% |
| AstraZeneca PLC | AZN | 2.08% |
| Roche Holding AG | ROG | 1.99% |
| Novartis AG | NOVN | 1.97% |
| Shell plc | SHEL | 1.90% |
| HSBC Holdings plc | HSBA | 1.85% |
| L'Oréal S.A. | OR | 1.58% |
| Schneider Electric S.E. | SU | 1.55% |